Skip to content

Clinical trials

Completed Graves Ophthalmopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Ophthalmopathy Status: Completed Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20132
20171
20181
20201
20212
20224
20236
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen8
Viridian Therapeutics, Inc.5
Hoffmann-La Roche2
Immunovant Sciences GmbH2
ACELYRIN Inc.1
Lassen Therapeutics Inc.1
Rebecca Bahn1
Sensimed AG1
Silkiss, Rona Z., M.D., FACS1
Sling Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Ophthalmopathy24
Exophthalmos5
Graves Disease5
Eye Diseases3
Autoimmune Diseases2
Endocrine System Diseases2
Orbital Diseases2
Bronchiolitis Obliterans Syndrome1
Hashimoto Disease1
Thyroid Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.